322 related articles for article (PubMed ID: 38049610)
1. The neurobiology of SARS-CoV-2 infection.
Meinhardt J; Streit S; Dittmayer C; Manitius RV; Radbruch H; Heppner FL
Nat Rev Neurosci; 2024 Jan; 25(1):30-42. PubMed ID: 38049610
[TBL] [Abstract][Full Text] [Related]
2. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders?
Murta V; Villarreal A; Ramos AJ
ASN Neuro; 2020; 12():1759091420954960. PubMed ID: 32878468
[TBL] [Abstract][Full Text] [Related]
3. Neurological manifestations of SARS-CoV-2: complexity, mechanism and associated disorders.
Tyagi K; Rai P; Gautam A; Kaur H; Kapoor S; Suttee A; Jaiswal PK; Sharma A; Singh G; Barnwal RP
Eur J Med Res; 2023 Aug; 28(1):307. PubMed ID: 37649125
[TBL] [Abstract][Full Text] [Related]
4. Role of aging in Blood-Brain Barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19.
Adesse D; Gladulich L; Alvarez-Rosa L; Siqueira M; Marcos AC; Heider M; Motta CS; Torices S; Toborek M; Stipursky J
Fluids Barriers CNS; 2022 Aug; 19(1):63. PubMed ID: 35982454
[TBL] [Abstract][Full Text] [Related]
5. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier?
Burks SM; Rosas-Hernandez H; Alejandro Ramirez-Lee M; Cuevas E; Talpos JC
Brain Behav Immun; 2021 Jul; 95():7-14. PubMed ID: 33412255
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
Proust A; Queval CJ; Harvey R; Adams L; Bennett M; Wilkinson RJ
J Neuroinflammation; 2023 Aug; 20(1):184. PubMed ID: 37537664
[TBL] [Abstract][Full Text] [Related]
7. Human brain organoids to explore SARS-CoV-2-induced effects on the central nervous system.
Ostermann PN; Schaal H
Rev Med Virol; 2023 Mar; 33(2):e2430. PubMed ID: 36790825
[TBL] [Abstract][Full Text] [Related]
8. The original strain of SARS-CoV-2, the Delta variant, and the Omicron variant infect microglia efficiently, in contrast to their inability to infect neurons: Analysis using 2D and 3D cultures.
Kase Y; Sonn I; Goto M; Murakami R; Sato T; Okano H
Exp Neurol; 2023 May; 363():114379. PubMed ID: 36914084
[TBL] [Abstract][Full Text] [Related]
9. Microglia Do Not Restrict SARS-CoV-2 Replication following Infection of the Central Nervous System of K18-Human ACE2 Transgenic Mice.
Olivarria GM; Cheng Y; Furman S; Pachow C; Hohsfield LA; Smith-Geater C; Miramontes R; Wu J; Burns MS; Tsourmas KI; Stocksdale J; Manlapaz C; Yong WH; Teijaro J; Edwards R; Green KN; Thompson LM; Lane TE
J Virol; 2022 Feb; 96(4):e0196921. PubMed ID: 34935438
[TBL] [Abstract][Full Text] [Related]
10. Role of the SARS-CoV-2 Virus in Brain Cells.
Azargoonjahromi A
Viral Immunol; 2024 Mar; 37(2):61-78. PubMed ID: 38315740
[TBL] [Abstract][Full Text] [Related]
11. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
12. What SARS-CoV-2 does to our brains.
Aschman T; Mothes R; Heppner FL; Radbruch H
Immunity; 2022 Jul; 55(7):1159-1172. PubMed ID: 35777361
[TBL] [Abstract][Full Text] [Related]
13. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
[TBL] [Abstract][Full Text] [Related]
14. Review of Neurological Manifestations of SARS-CoV-2.
Priyal ; Sehgal V; Kapila S; Taneja R; Mehmi P; Gulati N
Cureus; 2023 Apr; 15(4):e38194. PubMed ID: 37257164
[TBL] [Abstract][Full Text] [Related]
15. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet M; Sillett R; Zhu L; Mendel J; Camplisson I; Dercon Q; Harrison PJ
Lancet Psychiatry; 2022 Oct; 9(10):815-827. PubMed ID: 35987197
[TBL] [Abstract][Full Text] [Related]
16. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection.
Liu JM; Tan BH; Wu S; Gui Y; Suo JL; Li YC
J Med Virol; 2021 Mar; 93(3):1304-1313. PubMed ID: 33002209
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 invasion of the central nervous: a brief review.
Siddiqui R; Mungroo MR; Khan NA
Hosp Pract (1995); 2021 Aug; 49(3):157-163. PubMed ID: 33554684
[TBL] [Abstract][Full Text] [Related]
18. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
Zhou Z; Kang H; Li S; Zhao X
J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
[TBL] [Abstract][Full Text] [Related]
19. Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain.
Francistiová L; Klepe A; Curley G; Gulya K; Dinnyés A; Filkor K
Front Immunol; 2021; 12():730088. PubMed ID: 34484241
[TBL] [Abstract][Full Text] [Related]
20. SARS-Cov-2 infection and neuropathological findings: a report of 18 cases and review of the literature.
Lebrun L; Absil L; Remmelink M; De Mendonça R; D'Haene N; Gaspard N; Rusu S; Racu ML; Collin A; Allard J; Zindy E; Schiavo AA; De Clercq S; De Witte O; Decaestecker C; Lopes MB; Salmon I
Acta Neuropathol Commun; 2023 May; 11(1):78. PubMed ID: 37165453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
